Barchart
What Are Wall Street Analysts' Target Price for Biogen Stock?
📈
AI Sentiment
Highly Positive
8/10
Biogen Inc. News
Latest updates and market news for BIIB
9 news
Feb 10 - Feb 16, 2026
Page 1
MarketBeat
Biogen Spotlights Lupus Pipeline at Piper Sandler Symposium: Litifilimab, Dapirolizumab in Focus
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s Why
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Biogen's (NASDAQ:BIIB) Soft Earnings Don't Show The Whole Picture
📊
AI Sentiment
Positive
6/10
BioPharma Dive
Lyell starts first-of-its-kind CAR-T trial; New coalition aims to boost European biotechs
📈
AI Sentiment
Highly Positive
8/10
StockStory
The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call
📈
AI Sentiment
Highly Positive
8/10
StockStory
1 Unpopular Stock That Deserves a Second Chance and 2 We Find Risky
➖
AI Sentiment
Neutral
4/10
Share this news page